Researcher

de Vries, F.

Profileringshoogleraar, Hospital Pharmacist

View graph of relations
  1. 2019
  2. Published
    Hjellvik, V., De Bruin, M. L., Samuelsen, S. O., Karlstad, Ø., Andersen, M., Haukka, J., ... Furu, K. (2019). Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomes. Statistics in Medicine, 38(15), 2719-2734. https://doi.org/10.1002/sim.8131
  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. Published
  13. 2018
  14. Published
  15. Published
  16. Published
  17. Published
  18. Published
  19. Published
  20. Published
  21. Published
  22. Published
  23. Published
  24. Published
  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
  30. Published
  31. Published
  32. 2017
  33. Published
  34. Published
  35. Published
  36. Published
    But, A., De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., ... Haukka, J. (2017). Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study. Diabetologia, 60(9), 1691-1703. https://doi.org/10.1007/s00125-017-4312-5
  37. Published
    Wang, S. V., Schneeweiss, S., Berger, M. L., Brown, J., de Vries, F., Douglas, I., ... joint ISPE-ISPOR Special Task (2017). Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0. Value in Health, 20(8), 1009-1022. https://doi.org/10.1016/j.jval.2017.08.3018
  38. Published
    Wang, S. V., Schneeweiss, S., Berger, M. L., Brown, J., de Vries, F., Douglas, I., ... joint ISPE-ISPOR Special Task (2017). Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0. Pharmacoepidemiology and Drug Safety, 26(9), 1018-1032. https://doi.org/10.1002/pds.4295
  39. Published
  40. Published
  41. Published
  42. Published
  43. Published
  44. Published
  45. Published
  46. Published
    Hoenderboom, B. M., van Oeffelen, A. A. M., van Benthem, B. H. B., van Bergen, J. E. A. M., Dukers-Muijrers, N. H. T. M., Gotz, H. M., ... van den Broek, I. V. F. (2017). The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. BMC Infectious Diseases, 17, [264]. https://doi.org/10.1186/s12879-017-2376-y
  47. Published
  48. Published
  49. Published
  50. Published
  51. Published
  52. Published
  53. Published
  54. Published
  55. Published
  56. 2016
  57. Published
  58. Published
  59. Published
  60. Published
  61. Published
  62. Published
  63. Published
  64. Published
  65. Published
  66. Published
  67. Published
  68. Published
  69. Published
  70. Published
  71. Published
  72. Published
  73. Published
  74. Published
  75. Published
    Brauer, R., Ruigomez, A., Downey, G., Bate, A., Garcia Rodriguez, L. A., Huerta, C., ... Klungel, O. (2016). Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiology and Drug Safety, 25, 11-20. https://doi.org/10.1002/pds.3831
  76. Published
  77. Published
  78. Published
  79. Published
  80. Published
  81. Published
  82. Published
  83. Published
    Peeters, P. J. H. L., Bazelier, M. T., Leufkens, H. G. M., Auvinen, A., van Staa, T. P., de Vries, F., & De Bruin, M. L. (2016). Insulin glargine use and breast cancer risk: Associations with cumulative exposure. Acta Oncologica, 55(7), 851-858. https://doi.org/10.3109/0284186X.2016.1155736
  84. 2015
  85. Published
  86. Published
  87. Published
  88. Published
  89. Published
    Klop, C., Gibson-Smith, D., Elders, P. J. M., Welsing, P. M. J., Leufkens, H. G. M., Harvey, N. C., ... de Vries, F. (2015). Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporosis International, 26(7), 1919-1928. https://doi.org/10.1007/s00198-015-3098-x
  90. Published
  91. Published
    Klop, C., Welsing, P. M. J., Elders, P. J. M., Overbeek, J. A., Souverein, P. C., Burden, A. M., ... de Vries, F. (2015). Long-term persistence with anti-osteoporosis drugs after fracture. Osteoporosis International, 26(6), 1831-1840. https://doi.org/10.1007/s00198-015-3084-3
  92. Published
  93. Published
  94. Published
  95. Published
  96. Published
  97. Published
    Yska, J. P., van Roon, E. N., de Boer, A., Leufkens, H. G. M., Wilffert, B., de Heide, L. J. M., ... Lalmohamed, A. (2015). Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom. JAMA Surgery, 150(12), 1126-1133. https://doi.org/10.1001/jamasurg.2015.2398
  98. Published
  99. Published
  100. Published
  101. Published
  102. Published
  103. 2014
  104. Published
    Gibson-Smith, D., Klop, C., Elders, P. J. M., Welsing, P. M. J., van Schoor, N., Leufkens, H. G. M., ... de Vries, F. (2014). The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Osteoporosis International, 25(11), 2555-2563. https://doi.org/10.1007/s00198-014-2799-x
  105. Published
    Klop, C., Welsing, P. M. J., Cooper, C., Harvey, N. C., Elders, P. J. M., Bijlsma, J. W. J., ... de Vries, F. (2014). Mortality in British hip fracture patients, 2000-2010: A population-based retrospective cohort study. Bone, 66, 171-177. https://doi.org/10.1016/j.bone.2014.06.011
  106. Published
  107. Published
  108. Published
  109. Published
    Requena, G., Abbing-Karahagopian, V., Huerta, C., de Bruin, M. L., Alvarez, Y., Miret, M., ... de Abajo, F. J. (2014). Incidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records Databases. Calcified Tissue International, 94(6), 580-589. https://doi.org/10.1007/s00223-014-9850-y
  110. Published
  111. Published
    de Groot, M. C. H., Schuerch, M., de Vries, F., Hesse, U., Oliva, B., Gil, M., ... Klungel, O. H. (2014). Antiepileptic drug use in seven electronic health record databases in Europe: A methodologic comparison. Epilepsia, 55(5), 666-673. https://doi.org/10.1111/epi.12557
  112. Published
  113. Published
  114. Published
  115. Published
  116. Published
  117. Published
  118. Published
  119. Published
  120. Published
  121. Published
    Pouwels, S., de Boer, A., Leufkens, H. G. M., Weber, W. E. J., Cooper, C., van Onzenoort, H. A. W., & de Vries, F. (2014). Risk of fracture in patients with muscular dystrophies. Osteoporosis International, 25(2), 509-518. https://doi.org/10.1007/s00198-013-2442-2
  122. Published
  123. Published
  124. 2013
  125. Published
  126. Published
  127. Published
  128. Published
  129. Published
  130. Published
  131. Published
  132. Published
  133. Published
  134. Published
  135. 2012
  136. Published
    Klop, C., de Vries, F., Lalmohamed, A., Mastbergen, S. C., Leufkens, H. G. M., Noort-van der Laan, W. H., ... Welsing, P. M. J. (2012). COX-2-Selective NSAIDs and Risk of Hip or Knee Replacements: A Population-Based Case-Control Study. Calcified Tissue International, 91(6), 387-394. https://doi.org/10.1007/s00223-012-9646-x
  137. Published
    Lalmohamed, A., Vestergaard, P., Cooper, C., de Boer, A., Leufkens, H. G. M., van Staa, T. P., & de Vries, F. (2012). Timing of Stroke in Patients Undergoing Total Hip Replacement and Matched Controls A Nationwide Cohort Study. Stroke, 43(12), 3225-3229. https://doi.org/10.1161/STROKEAHA.112.668509
  138. Published
    Bazelier, M. T., Bentzen, J., Vestergaard, P., Stenager, E., Leufkens, H. G. M., van Staa, T-P., & de Vries, F. (2012). The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers. Multiple Sclerosis Journal, 18(11), 1609-1616. https://doi.org/10.1177/1352458512442755
  139. Published
  140. Published
    Lalmohamed, A., de Vries, F., Bazelier, M. T., Cooper, A., van Staa, T-P., Cooper, C., & Harvey, N. C. (2012). Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ (e), 345, [e5085]. https://doi.org/10.1136/bmj.e5085
  141. Published
  142. Published
    Bazelier, M. T., Vestergaard, P., Gallagher, A. M., van Staa, T-P., Cooper, C., Leufkens, H. G. M., & de Vries, F. (2012). Risk of Fracture with Thiazolidinediones: Disease or Drugs? Calcified Tissue International, 90(6), 450-457. https://doi.org/10.1007/s00223-012-9591-8
  143. Published
    Bazelier, M. T., van Staa, T. P., Uitdehaag, B. M. J., Cooper, C., Leufkens, H. G. M., Vestergaard, P., ... de Vries, F. (2012). Risk of fractures in patients with multiple sclerosis A population-based cohort study. Neurology, 78(24), 1967-1973. https://doi.org/10.1212/WNL.0b013e318259e0ff
  144. Published
    Lalmohamed, A., Welsing, P. M. J., Lems, W. F., Jacobs, J. W. G., Kanis, J. A., Johansson, H., ... De Vries, F. (2012). Calibration of FRAX (R) 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporosis International, 23(3), 861-869. https://doi.org/10.1007/s00198-011-1852-2